Switching to peginterferon for chronic hepatitis B patients with hepatitis B e antigen seroconversion on entecavir - A prospective study-Reference-Cited by-同舟云学术

Switching to peginterferon for chronic hepatitis B patients with hepatitis B e antigen seroconversion on entecavir - A prospective study

Published:2018-10-18 Issue:1 Volume:26 Page:126-135
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Chan Henry L. Y.¹^ORCID,Chan Fiona W. S.²,Hui Aric J.³,Li Michael K. K.⁴,Chan Kam H.⁵,Wong Grace L. H.¹,Loo Ching K.²,Chim Angel M. L.¹,Tse Chi H.¹,Wong Vincent W. S.¹

Affiliation:

1. Department of Medicine and Therapeutics and Institute of Digestive Disease; The Chinese University of Hong Kong; Hong Kong

2. Department of Medicine; Kwong Wah Hospital; Hong Kong

3. Department of Medicine; Alice Ho Miu Ling Nethersole Hospital; Hong Kong

4. Department of Medicine; Tuen Mun Hospital; Hong Kong

5. Department of Medicine; North District Hospital; Hong Kong

Funder

Roche

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jvh.13000/fullpdf

Reference35 articles.

1. Infection and cancer: the case of hepatitis B;Chan;J Clin Oncol,2016

2. Meta-analysis: treatment of hepatitis B infection reduces risk of hepato-cellular carcinoma;Sung;Aliment Pharmacol Ther,2008

3. Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients with liver cirrhosis;Wong;Hepatology,2013

4. Risk of hepatocellular carcinoma in chronic hepatitis B: assessment and modification with current antiviral therapy;Papatheodoridis;J Hepatol,2015

5. Long-term safety of oral nucleos(t)ide analogues for patients with chronic hepatitis B - a cohort study of 53,500 subjects;Wong;Hepatology,2015

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022);Journal of Clinical and Translational Hepatology;2023-08-15

2. Serum cytokine change profile associated with HBsAg loss during combination therapy with PEG-IFN-α in NAs-suppressed chronic hepatitis B patients;Frontiers in Immunology;2023-01-23

3. Lower frequency of MDSCs was significantly related to functional cure in CHB patients treated with peginterferon;Liver International;2022-12-07

4. Quantitative anti-HBc combined with quantitative HBsAg can predict HBsAg clearance in sequential combination therapy with PEG-IFN-α in NA-suppressed chronic hepatitis B patients;Frontiers in Immunology;2022-07-26

5. Real‐world study on HBsAg loss of combination therapy in HBeAg ‐negative chronic hepatitis B patients;Journal of Viral Hepatitis;2022-07-06